This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Antihypertensive Therapy and the J Curve

Myron H. Weinberger, MD

Arch Intern Med. 1992;152(3):473-476.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Despite tremendous advances in our knowledge of the factors responsible for cardiovascular disease, massive detection and public and professional education programs, and the introduction of effective new agents for the treatment of these risk factors, cardiovascular disease remains the number 1 cause of death in America and most of the industrialized world. Hypertension remains a major risk factor for these disorders despite marked improvement in the identification of those with elevated blood pressure and its treatment. The introduction of antihypertensive drugs more than 30 years ago was met with lukewarm utilization until the publication of the dramatic results of the Veterans Administration Cooperative Study in patients with severe hypertension (diastolic pressure >114 mm Hg).¹ This study reported a marked decrease in mortality with antihypertensive therapy in comparison with a group receiving placebo only. Subsequent reports by the same investigative group in those with mild to moderate hypertension, although not . . . [Full Text PDF of this Article]

Author Affiliations
Hypertension Research Center Indiana University School of Medicine 541 Clinical Dr, Room 409 Indianapolis, IN 46202-5111

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?